{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:49:35Z","timestamp":1755218975600,"version":"3.43.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11401-3","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:34:49Z","timestamp":1754494489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Depression mediates the association between lipid accumulation products and overactive bladder"],"prefix":"10.1038","volume":"15","author":[{"given":"Caijuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"1","key":"11401_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2022.01.045","volume":"82","author":"AK Nambiar","year":"2022","unstructured":"Nambiar, A. K. et al. European association of urology guidelines on the diagnosis and management of female Non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur. Urol. 82 (1), 49\u201359. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.045 (2022).","journal-title":"Eur. Urol."},{"issue":"6","key":"11401_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet, B. et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the W ay to Tailored Treatment. European urology 75 (6), 988\u20131000. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.038 (2019).","journal-title":"European urology"},{"issue":"6","key":"11401_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart, W. F. et al. Prevalence and burden of overactive bladder in the united States. World J. Urol. 20 (6), 327\u2013336. https:\/\/doi.org\/10.1007\/s00345-002-0301-4 (2003).","journal-title":"World J. Urol."},{"issue":"1","key":"11401_CR4","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1038\/s41598-024-63448-3","volume":"14","author":"B Wei","year":"2024","unstructured":"Wei, B. et al. The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci. Rep. 14 (1), 12579. https:\/\/doi.org\/10.1038\/s41598-024-63448-3 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"11401_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ogc.2015.10.002","volume":"43","author":"N White","year":"2016","unstructured":"White, N. & Iglesia, C. B. Overactive Bladder. Obstetrics Gynecol. Clin. North. America 43 (1), 59\u201368. https:\/\/doi.org\/10.1016\/j.ogc.2015.10.002 (2016).","journal-title":"Obstetrics Gynecol. Clin. North. America"},{"issue":"6","key":"11401_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet, B. et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur. Urol. 75 (6), 988\u20131000. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.038 (2019).","journal-title":"Eur. Urol."},{"issue":"5","key":"11401_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.eururo.2009.07.044","volume":"56","author":"A Roosen","year":"2009","unstructured":"Roosen, A. et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: A systematic review of the latest literature. Eur. Urol. 56 (5), 810\u2013820. https:\/\/doi.org\/10.1016\/j.eururo.2009.07.044 (2009).","journal-title":"Eur. Urol."},{"issue":"4","key":"11401_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/nau.23170","volume":"36","author":"A Apostolidis","year":"2017","unstructured":"Apostolidis, A. et al. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015). Neurourol. Urodyn. 36 (4), 882\u2013893. https:\/\/doi.org\/10.1002\/nau.23170 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"11401_CR9","doi-asserted-by":"publisher","first-page":"1423148","DOI":"10.3389\/fnut.2024.1423148","volume":"11","author":"Z Hui","year":"2024","unstructured":"Hui, Z., Zewu, Z., Yang, L. & Yu, C. Association between weight-adjusted waist index and overactive bladder: a cross-sectional study based on 2009\u20132018 NHANES. Front. Nutr. 11, 1423148. https:\/\/doi.org\/10.3389\/fnut.2024.1423148 (2024).","journal-title":"Front. Nutr."},{"issue":"1","key":"11401_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12905-024-03339-x","volume":"24","author":"Y Shang","year":"2024","unstructured":"Shang, Y., Chen, J. & Tai, Y. Association between weight-adjusted waist index and overactive bladder syndrome among adult women in the united states: a cross-sectional study. BMC Womens Health. 24 (1), 488. https:\/\/doi.org\/10.1186\/s12905-024-03339-x (2024).","journal-title":"BMC Womens Health"},{"issue":"4","key":"11401_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5213\/inj.2012.16.4.181","volume":"16","author":"H Uzun","year":"2012","unstructured":"Uzun, H., Yilmaz, A., Kemik, A., Zorba, O. U. & Kalkan, M. Association of insulin resistance with overactive bladder in female patients. Int. Neurourol. J. 16 (4), 181\u2013186. https:\/\/doi.org\/10.5213\/inj.2012.16.4.181 (2012).","journal-title":"Int. Neurourol. J."},{"issue":"2","key":"11401_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.22037\/uj.v0i0.4886","volume":"17","author":"B Yuksel","year":"2020","unstructured":"Yuksel, B. et al. Association of severity of lower extremity arterial disease and overactive bladder syndrome: A cross sectional study. Urol. J. 17 (2), 180\u2013184. https:\/\/doi.org\/10.22037\/uj.v0i0.4886 (2020).","journal-title":"Urol. J."},{"issue":"1","key":"11401_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12944-024-02174-1","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Association between body roundness index and overactive bladder: results from the NHANES 2005\u20132018. Lipids Health Dis. 23 (1), 184. https:\/\/doi.org\/10.1186\/s12944-024-02174-1 (2024).","journal-title":"Lipids Health Dis."},{"issue":"12","key":"11401_CR14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11255-014-0832-9","volume":"46","author":"M Dursun","year":"2014","unstructured":"Dursun, M. et al. Stress urinary incontinence and visceral adipose index: a new risk parameter. Int. Urol. Nephrol. 46 (12), 2297\u20132300. https:\/\/doi.org\/10.1007\/s11255-014-0832-9 (2014).","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"11401_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3803\/EnM.2022.101","volume":"37","author":"EJ Rhee","year":"2022","unstructured":"Rhee, E. J. The influence of obesity and metabolic health on vascular health. Endocrinol. Metab. (Seoul). 37 (1), 1\u20138. https:\/\/doi.org\/10.3803\/EnM.2022.101 (2022).","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"11401_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnut.2020.00053","volume":"7","author":"LM Donini","year":"2020","unstructured":"Donini, L. M., Pinto, A., Giusti, A. M., Lenzi, A. & Poggiogalle, E. Obesity or BMI paradox?? Beneath the tip of the iceberg. Front. Nutr. 7, 53. https:\/\/doi.org\/10.3389\/fnut.2020.00053 (2020).","journal-title":"Front. Nutr."},{"issue":"2","key":"11401_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40519-016-0278-4","volume":"21","author":"O Bosello","year":"2016","unstructured":"Bosello, O., Donataccio, M. P. & Cuzzolaro, M. Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eat. Weight Disord. 21 (2), 165\u2013174. https:\/\/doi.org\/10.1007\/s40519-016-0278-4 (2016).","journal-title":"Eat. Weight Disord"},{"issue":"1","key":"11401_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12944-024-02123-y","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang, C., Dong, X., Chen, J. & Liu, F. Association between lipid accumulation product and psoriasis among adults: a nationally representative cross-sectional study. Lipids Health Dis. 23 (1), 143. https:\/\/doi.org\/10.1186\/s12944-024-02123-y (2024).","journal-title":"Lipids Health Dis."},{"key":"11401_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn, H. S. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 5, 26. https:\/\/doi.org\/10.1186\/1471-2261-5-26 (2005).","journal-title":"BMC Cardiovasc. Disord"},{"key":"11401_CR20","doi-asserted-by":"publisher","first-page":"889785","DOI":"10.3389\/fendo.2022.889785","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Association between four anthropometric indexes and metabolic syndrome in US adults. Front. Endocrinol. (Lausanne). 13, 889785. https:\/\/doi.org\/10.3389\/fendo.2022.889785 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"11401_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.juro.2017.04.103","volume":"198","author":"HE Richter","year":"2017","unstructured":"Richter, H. E. et al. Characteristics associated with treatment response and satisfaction in women undergoing OnabotulinumtoxinA and sacral neuromodulation for refractory urgency urinary incontinence. J. Urol. 198 (4), 890\u2013896. https:\/\/doi.org\/10.1016\/j.juro.2017.04.103 (2017).","journal-title":"J. Urol."},{"issue":"8","key":"11401_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/nau.23256","volume":"36","author":"LL Lua","year":"2017","unstructured":"Lua, L. L., Pathak, P. & Dandolu, V. Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents. Neurourol. Urodyn. 36 (8), 2123\u20132131. https:\/\/doi.org\/10.1002\/nau.23256 (2017).","journal-title":"Neurourol. Urodyn."},{"issue":"2","key":"11401_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/nau.22809","volume":"35","author":"AT Hanna-Mitchell","year":"2016","unstructured":"Hanna-Mitchell, A. T., Robinson, D., Cardozo, L., Everaert, K. & Petkov, G. V. Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014. Neurourol. Urodyn. 35  (2), 299\u2013303. https:\/\/doi.org\/10.1002\/nau.22809 (2016).","journal-title":"Neurourol. Urodyn."},{"issue":"6","key":"11401_CR24","doi-asserted-by":"publisher","first-page":"F1253","DOI":"10.1152\/ajprenal.00238.2016","volume":"311","author":"KL Hristov","year":"2016","unstructured":"Hristov, K. L., Parajuli, S. P., Provence, A. & Petkov, G. V. Testosterone decreases urinary bladder smooth muscle excitability via novel signaling mechanism involving direct activation of the BK channels. Am. J. Physiol. - Ren. Physiol. 311 (6), F1253\u2013F1259. https:\/\/doi.org\/10.1152\/ajprenal.00238.2016 (2016).","journal-title":"Am. J. Physiol. - Ren. Physiol."},{"issue":"5","key":"11401_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00210-017-1355-6","volume":"390","author":"G Bravo","year":"2017","unstructured":"Bravo, G. et al. Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release. Naunyn. Schmiedebergs Arch. Pharmacol. 390 (5), 547\u2013556. https:\/\/doi.org\/10.1007\/s00210-017-1355-6 (2017).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"11401_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/andr.13355","volume":"11","author":"Q Liu","year":"2023","unstructured":"Liu, Q., Huang, Y., Wang, M., Jiang, H. & Zhang, X. Association of lipid accumulation products with testosterone deficiency in adult American men: A cross-sectional study. Andrology 11 (3), 551\u2013560. https:\/\/doi.org\/10.1111\/andr.13355 (2023).","journal-title":"Andrology"},{"issue":"2","key":"11401_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychores.2014.11.019","volume":"78","author":"D Vrijens","year":"2015","unstructured":"Vrijens, D. et al. Affective symptoms and the overactive bladder - A systematic review. J. Psychosom. Res. 78 (2), 95\u2013108. https:\/\/doi.org\/10.1016\/j.jpsychores.2014.11.019 (2015).","journal-title":"J. Psychosom. Res."},{"key":"11401_CR28","doi-asserted-by":"publisher","first-page":"1395766","DOI":"10.3389\/fpsyt.2024.1395766","volume":"15","author":"X Zhu","year":"2024","unstructured":"Zhu, X. et al. The relationship between depression and lipid accumulation product: a population-based study. Front. Psychiatry. 15, 1395766. https:\/\/doi.org\/10.3389\/fpsyt.2024.1395766 (2024).","journal-title":"Front. Psychiatry"},{"issue":"6","key":"11401_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/00912174241265559","volume":"59","author":"M Dai","year":"2024","unstructured":"Dai, M., Zhang, Y., Chen, Y., Wang, L. & Tian, Y. The association between lipid accumulation products and depression in U.S. Adults: A cross-sectional study from NHANES 2005\u20132018. Int. J. Psychiatry Med. 59 (6), 685\u2013701. https:\/\/doi.org\/10.1177\/00912174241265559 (2024).","journal-title":"Int. J. Psychiatry Med."},{"key":"11401_CR30","doi-asserted-by":"publisher","first-page":"102898","DOI":"10.1016\/j.pmedr.2024.102898","volume":"47","author":"W Yao","year":"2024","unstructured":"Yao, W. et al. The association between education level and overactive bladder: evidence from a U.S. population-based study. Prev. Med. Rep. 47, 102898. https:\/\/doi.org\/10.1016\/j.pmedr.2024.102898 (2024).","journal-title":"Prev. Med. Rep."},{"key":"11401_CR31","doi-asserted-by":"publisher","first-page":"1137191","DOI":"10.3389\/fpubh.2023.1137191","volume":"11","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. A positive association between the prevalence of circadian syndrome and overactive bladder in united States adults. Front. Public. Health. 11, 1137191. https:\/\/doi.org\/10.3389\/fpubh.2023.1137191 (2023).","journal-title":"Front. Public. Health"},{"issue":"1","key":"11401_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.amjmed.2022.08.031","volume":"136","author":"S Zhu","year":"2023","unstructured":"Zhu, S., Wang, Z., Tao, Z., Wang, S. & Wang, Z. Relationship between marijuana use and overactive bladder (OAB): A Cross-Sectional research of NHANES 2005 to 2018. Am. J. Med. 136 (1), 72\u201378. https:\/\/doi.org\/10.1016\/j.amjmed.2022.08.031 (2023).","journal-title":"Am. J. Med."},{"issue":"9","key":"11401_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12603-023-1972-3","volume":"27","author":"W Song","year":"2023","unstructured":"Song, W. et al. The role of sarcopenia in overactive bladder in adults in the united states: retrospective analysis of NHANES 2011\u20132018. J. Nutr. Health Aging. 27 (9), 734\u2013740. https:\/\/doi.org\/10.1007\/s12603-023-1972-3 (2023).","journal-title":"J. Nutr. Health Aging"},{"key":"11401_CR34","doi-asserted-by":"publisher","first-page":"1453062","DOI":"10.3389\/fnut.2024.1453062","volume":"11","author":"J Zhou","year":"2024","unstructured":"Zhou, J., Liu, W., Liu, X., Wu, J. & Chen, Y. Independent and joint influence of depression and advanced lung cancer inflammation index on mortality among individuals with chronic kidney disease. Front. Nutr. 11, 1453062. https:\/\/doi.org\/10.3389\/fnut.2024.1453062 (2024).","journal-title":"Front. Nutr."},{"issue":"9","key":"11401_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke, K., Spitzer, R. L. & Williams, J. B. W. The PHQ-9. J. Gen. Intern. Med. 16 (9), 606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x (2001).","journal-title":"J. Gen. Intern. Med."},{"issue":"7","key":"11401_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11934-022-01097-7","volume":"23","author":"W Clearwater","year":"2022","unstructured":"Clearwater, W., Kassam, F., Aalami Harandi, A., Tenggardjaja, C. F. & Abraham, N. Combination and novel Pharmacologic agents for OAB. Curr. Urol. Rep. 23 (7), 129\u2013141. https:\/\/doi.org\/10.1007\/s11934-022-01097-7 (2022).","journal-title":"Curr. Urol. Rep."},{"issue":"1","key":"11401_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He, Q. et al. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 19 (1), 7\u201313. https:\/\/doi.org\/10.1038\/pcan.2015.43 (2016).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"11401_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ijcp.12518","volume":"69","author":"F Bunn","year":"2015","unstructured":"Bunn, F. et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int. J. Clin. Pract. 69 (2), 199\u2013217. https:\/\/doi.org\/10.1111\/ijcp.12518 (2015).","journal-title":"Int. J. Clin. Pract."},{"key":"11401_CR39","doi-asserted-by":"crossref","unstructured":"Klausner AP, Steers WD: Corticotropin releasing factor: A mediator of emotional influences on bladder function. In. J. Urol. 2004, 2570\u20132573.  (2004).","DOI":"10.1097\/01.ju.0000144142.26242.f3"},{"key":"11401_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejphar.2017.07.010","volume":"812","author":"A Wr\u00f3bel","year":"2017","unstructured":"Wr\u00f3bel, A., Doboszewska, U., Rechberger, E., Wla\u017a, P. & Rechberger, T. SN003, a CRF1 receptor antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13-cis-retinoic acid in rats. Eur. J. Pharmacol. 812, 216\u2013224. https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.010 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"11401_CR41","doi-asserted-by":"crossref","unstructured":"De Groat WC: Influence of central serotonergic mechanisms on lower urinary tract function. In. Urol. 2002, 30\u201336.  (2002).","DOI":"10.1016\/S0090-4295(01)01636-3"},{"issue":"8","key":"11401_CR42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/nau.22843","volume":"35","author":"H Chiba","year":"2016","unstructured":"Chiba, H. et al. The role of serotonergic mechanism in the rat prefrontal cortex for controlling the micturition reflex: an in vivo Microdialysis study. Neurourol. Urodyn. 35 (8), 902\u2013907. https:\/\/doi.org\/10.1002\/nau.22843 (2016).","journal-title":"Neurourol. Urodyn."},{"issue":"6","key":"11401_CR43","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11255-023-03935-0","volume":"56","author":"M Zhang","year":"2024","unstructured":"Zhang, M., Zhang, J., Cui, Y. & Xing, Z. Predictive power of lipid-related indicators for testosterone deficiency: a comparative analysis, NHANES 2011\u20132016. Int. Urol. Nephrol. 56 (6), 1825\u20131833. https:\/\/doi.org\/10.1007\/s11255-023-03935-0 (2024).","journal-title":"Int. Urol. Nephrol."},{"issue":"3","key":"11401_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/13685538.2013.807426","volume":"16","author":"CAV De Barros","year":"2013","unstructured":"De Barros, C. A. V., Lorenzetti, F., Ortiz, V. & Dambros, M. Testosterone supplementation\u2019s effects on age-related bladder remodeling-experimental study in rats. Aging Male. 16 (3), 102\u2013107. https:\/\/doi.org\/10.3109\/13685538.2013.807426 (2013).","journal-title":"Aging Male"},{"issue":"1","key":"11401_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.juro.2017.07.039","volume":"199","author":"KS Haider","year":"2018","unstructured":"Haider, K. S., Haider, A., Doros, G. & Traish, A. Long-Term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J. Urol. 199 (1), 257\u2013265. https:\/\/doi.org\/10.1016\/j.juro.2017.07.039 (2018).","journal-title":"J. Urol."},{"issue":"11","key":"11401_CR46","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00345-015-1496-5","volume":"33","author":"KC Lee","year":"2015","unstructured":"Lee, K. C. Changes of muscarinic receptors and connexin-43 expression as a mechanism of overactive bladder in ovariectomized rats. World J. Urol. 33 (11), 1875\u20131879. https:\/\/doi.org\/10.1007\/s00345-015-1496-5 (2015).","journal-title":"World J. Urol."},{"key":"11401_CR47","first-page":"CD001405","volume":"10","author":"JD Cody","year":"2012","unstructured":"Cody, J. D., Jacobs, M. L., Richardson, K., Moehrer, B. & Hextall, A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst. Reviews (Online). 10, CD001405 (2012).","journal-title":"Cochrane Database Syst. Reviews (Online)"},{"issue":"9","key":"11401_CR48","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/gme.0b013e3182104977","volume":"18","author":"RS Nelken","year":"2011","unstructured":"Nelken, R. S., \u00d6zel, B. Z., Leegant, A. R., Felix, J. C. & Mishell, D. R. Jr Randomized trial of estradiol vaginal ring versus oral Oxybutynin for the treatment of overactive bladder. Menopause 18 (9), 962\u2013966. https:\/\/doi.org\/10.1097\/gme.0b013e3182104977 (2011).","journal-title":"Menopause"},{"issue":"2","key":"11401_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/aps.2010.198","volume":"32","author":"S Jeong","year":"2011","unstructured":"Jeong, S. & Yoon, M. 17\u03b2-Estradiol Inhibition of PPAR\u03b3-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol. Sin. 32 (2), 230\u2013238. https:\/\/doi.org\/10.1038\/aps.2010.198 (2011).","journal-title":"Acta Pharmacol. Sin"},{"issue":"3","key":"11401_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/jme-13-0273","volume":"52","author":"R Zhang","year":"2014","unstructured":"Zhang, R. et al. Estrogen suppresses adipogenesis by inhibiting S100A16 expression. J. Mol. Endocrinol. 52 (3), 235\u2013244. https:\/\/doi.org\/10.1530\/jme-13-0273 (2014).","journal-title":"J. Mol. Endocrinol."},{"issue":"1","key":"11401_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12894-016-0179-x","volume":"16","author":"HH Lai","year":"2016","unstructured":"Lai, H. H., Shen, B., Rawal, A. & Vetter, J. The relationship between depression and overactive bladder\/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 16 (1), 60. https:\/\/doi.org\/10.1186\/s12894-016-0179-x (2016).","journal-title":"BMC Urol."},{"issue":"S4","key":"11401_CR52","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1002\/nau.23506","volume":"37","author":"A Apostolidis","year":"2018","unstructured":"Apostolidis, A. et al. Is there brain OAB and how can we recognize it? International consultation on Incontinence-Research society (ICI-RS) 2017. Neurourol. Urodyn. 37 (S4), S38\u2013s45. https:\/\/doi.org\/10.1002\/nau.23506 (2018).","journal-title":"Neurourol. Urodyn."},{"issue":"3","key":"11401_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/nau.25662","volume":"44","author":"M Van den Ende","year":"2025","unstructured":"Van den Ende, M. et al. Should we be treating affective symptoms, like anxiety and depression which May be related to LUTD in patients with OAB? ICI-RS 2024. Neurourol. Urodyn. 44 (3), 661\u2013667. https:\/\/doi.org\/10.1002\/nau.25662 (2025).","journal-title":"Neurourol. Urodyn."},{"issue":"5","key":"11401_CR54","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00345-023-04351-w","volume":"41","author":"L Zuluaga","year":"2023","unstructured":"Zuluaga, L. et al. Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study. World J. Urol. 41 (5), 1381\u20131388. https:\/\/doi.org\/10.1007\/s00345-023-04351-w (2023).","journal-title":"World J. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11401-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:34:51Z","timestamp":1754494491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11401-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11401-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from each participant in this study. The National Center for Health Statistics (NCHS) Ethics Review Board approved the NHANES data collection procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"28797"}}